Head, Oncology Ambulatory Services
Department of Oncology
Hadassah University Hospital
Ein-Karem, Jerusalem
Date & Place of Birth: April 14, 1954, Romania
Marital Status: Married + 3 children
Education
1972-1974 Military Service
1974-1975 Hebrew University, Department of Biology
1975-1981 Hebrew University-Hadassah Medical School
1982-1983 Internship, Hadassah Hospital
1983-1989 Resident, Department of Radiation & Clinical Oncology, Sharett Institute of Oncology, Hadassah University Hospital, Jerusalem, Israel.
1989- Senior Physician, Hadassah Hospital
Professional Experience
September 1985 - Instructor, Medical Oncology and Radiotherapy
June 1986 - Board Exam, Oncology, Part I.
March 1989 - Board Exam, Medical Oncology and Radiotherapy, Part II.
May 1989 - Senior Physician, Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center.
August 1992 - Research Fellow, USC/Norris Cancer Center, L.A., U.S.A.
October 1994 - Lecturer, Medical Oncology/Radiation Oncology, Hebrew University, Jerusalem.
October 1999 - Clinical Senior Lecturer, Medical Oncology/ Radiation Oncology, Hebrew University Jerusalem
December 2001 - Head, Oncology Ambulatory Services Unit
Awards
Medical School Scholarship for Excellence.
The Lando Award for Clinical Research Study. “Management of Metastatic Thyroid Cancer:” $ 2000
1995 - The Hebrew University Faculty Prize - Distinguished Research Work, June 1995
Grants
1987 - Research Grant: The Joint Research Fund of the Hebrew University and Hadassah University Hospital, "The Role of Mycoplasma in TNF Production and Macrophage Mediated." Beatrice Uziely, M.D
1993 - 1994 Lymphoma Research Foundation of America, Inc. “MDR in Lymphoma Impact on Taxol Response and Resistance-Reversal Strategy”. Beatrice Uziely, M.D. $30000
1998 - Hadassah Medical Organization: A Collaborative Grant for Research in Women's Health. " In Vitro Effects of Melatonin: Regulation of Thrombin Receptor Expression in Epithelial Breast Cancer Cell Lines." Beatrice Uziely, M.D., Rachel Bar-Shavit, Ph.D., Amnon Brzezinski M.D. $6000
1999 - The Joint Research Fund of The Hebrew University and Hadassah, Hospital. "The Role of Protease Activated Receptors (PAR) Family in Breast Carcinoma Invasion and Metastases." Beatrice Uziely, M.D. $10000
1999 - Middle East Cancer Consortium, "The Role of the Protease Activated Receptor (PAR) Family in Tumor Metastasis". Beatrice Uziely, M.D., Maher Sughay, M.D., Rachel Bar-Shavit, Ph.D. $30000
1999 - Horowitz Fund, "Protease Activated Receptors (PARs) Over-expression in Malignant and Physiological Invasion Processes". Rachel Bar-Shavit, Ph.D., Beatrice Uziely, M.D., Sorina Grisaru-Granovsky, M.D. $50000
1999 - Ministry of Health, "The Involvement of PAR in the Malignant Invasion Process." Rachel Bar-Shavit, Ph.D., Beatrice Uziely, M.D., Sorina Grisaru-Granovsky, M.D. $15000.
1999-2002 Horowitz Grant for Applied Research, Rachel Bar-Shavit, Ph.D., Beatrice Uziely, M.D., Sorina Grisaru-Granovsky. $56000/y
1999-2002 US Army Medical Research and Material Command, "Protease Activated Receptors (PARs) in the Malignant Invasion Process", Rachel Bar-Shavit Ph.D., Beatrice Uziely M.D. $256000
2000 - CapCure Association for the Cure of Prostate Cancer, "The Role of Protease Activated Receptor (PAR) Family in Prostate Carcinoma Invasion and Metastasis." Rachel Bar-Shavit, Ph.D. Beatrice Uziely, M.D. $75000
2002 - Israel Cancer Association, “Motivation to give birth after breast cancer”, Professor Lea Baider, Beatrice Uziely, M.D. Shekel 40000.
Teaching Experience
1994 -1999 Coordinator, Teaching Program for Medical Students in Oncology (Lectures Program and Bedside Teaching).
1994 -1999 Coordinator, Teaching Program for Residents and Fellows in Oncology. (Lectures, Bedside Teaching and Journal Club)
1999 - Member, Problem Base Learning (P.B.L.) Team, 5th Year Medical School
Tutor - M.A. Thesis
October 1998 Chana Thalia Bengal
Master Thesis - Mentor for Graduate Program in Public Health
(MPH), Hebrew University - Hadassah Medical School "An Analysis of Screening Mammography in Women between the Ages of 40-49 in Israel".
Membership in Committees
1998 and 1999 Member, Committee for Academic Examination in Medicine, Hebrew University - Hadassah Medical School
Medical Societies
· Israel Medical Association
· Israel Society of Clinical Oncology
· American Society of Clinical Oncology
· European Society for Medical Oncology
Abstracts
1. Anteby, S.O., Uziely, B., Kopolovitz, U.: Mixed Mesodermal Tumor of the Uterus. Clinico-pathalogical Correlation. 8th Congress of the Israel Association of Obstetrics & Gynecology, (Hebrew) 1984.
2. Uziely, B., Sulkes, A. Libson, B., Isacson, R., Gez, E., Levy, F., Fridkin, M. and Catane, R.: A Phase II Study of Tuftsin for the Treatment of Non-small Cell Carcinoma of the Lung. 4th Mediterranean Congress of Chemotherapy, 896: 506, 1984.
3. Isacson, R., Yablonski-Peretz, T., Uziely, B., Sulkes, A., Biran, S.: High Dose Folinic Acid and 5-Fluorouracil in G.I. Malignancies. 4th Mediterranean Congress of Chemotherapy 854: 484, 1984.
4. Isacson, R., Yablonsky-Peretz, T., Uziely, B., Sulkes, A., Biran, S.: High Dose Folinic Acid and 5-Fluorouracil in Gastrointestinal Malignancies. Proceedings of 4th Mediterranean Congress of Chemotherapy, 1153-1156, 1984.
5. Peretz, T., Uziely, B., Sulkes, A., Biran, S., Catane, R.: Combination Chemotherapy for Sqamous Cell Carcinoma of Head and Neck. ECCO 3 Stockholm, 58: 24, 1985.
6. Catane, R., Sulkes, A., Warner-Efrati, E. Uziely, B., Ben-Baruch, N., Fridkin, M., Biran, S.: Clinical Trials with Immunomodulator Tuftsin. ECCO 3 Stockholm, 58:24, 1985.
7. Uziely, B., Isacson, R., Gez, B., Peretz, T., Sulkes, A.: Mitomycin C (MMC) in Patients with Metastatic Gastrointestinal Cancer who Failed Previous Chemotherapy. EORTC Symposium on Gastrointestinal Tract Cancer Update on Combined Modality Therapy, 1986.
8. Gez, E., Warner, E., Ben-Baruch, N., Ben-Yosef, R., Uziely, B., Ben-Dor, C., Yitzhaki-Engel, N, Biran, S.: High Dose Metoclopramide and Dexamethasone as an Antiemetic in Breast Cancer Patients Undergoing Chemotherapy. The 5th Mediterranean Congress of Chemotherapy 398, 1986.
9. Warner, E., Sulkes, A., Gez, E., Uziely, B., Ben-Baruch, N., Ben-Yosef, R., Biran, S., Catane, R.: Combine Immunotherapy and Chemotherapy with Tuftsin plus Cyclophosphomide in the treatment of Non-small Cell Lung Cancer. The 5th Mediterranean Congress of Chemotherapy, 1986.
10. Uziely, B., Isacson, R., Weshler, Z., Yahalom, A., Lugassy, G., Ruchlemer, R., Gez, E.. Polliack, A.: Hodgkin’s Lymphoma; Results of ABVD Chemotherapy in Advanced Disease. ECCO-4th European Conference on Clinical Oncology and Cancer Nursing : 272, 1987.
11. Sher, T., Uziely B., Ehrlich, Y., Yamin, A., Stein, I., Rottem, S., Gallily, R.: Induction of Tumor Necrosis Factor and Tumor Cell Killing by Membranes of Mycoplasma Capricolum. 18th Annual Meeting of The Israeli Immunological Society, May 26, 1988.
12. Uziely B., Krausz, Y., Wygoda, M., Isacson, R., Drucker, M., Catane, R.: Management of Metastatic Thyroid Cancer. The European J. of Cancer, Supp. 2, Abs.# 1916 (ECCO), 1991.
13. Isacson, R., Sulkes, A., Kaufman, B., Uziely, B., Catane, R.: Platinum (DDP), DTIC, Bleomycin (Bleo) and Vinblastine (VBL) in Metastatc Malignant Melanoma. The European J. of Cancer, Supp. 2, Abs# 952, 1991.
14. Wygoda, M., Peretz, T., Sulkes, A. Brufman, G., Uziely, B., Rozenman, E., Durst, A.L., Catane, R.: Neoadjuvant CAF (Cytoxan, Doxorubicin and 5FU) Chemotherapy for Clinical Stage III Breast Cancer Patients. Third International Congress in Neo-Adjuvant Chemotherapy. Paris, France. February 6-9, 1991.
15. Brufman, G., Uziely, B., Dracos, P., Gera-Ben Dor, C., Catane, R.: Adjuvant DMF versus CXF in Stage II Breast Cancer Randomized Pilot Study, 1991.
16. Brufman, G., Uziely,B., Gera-Ben Dor, C., Catane, R.: Adjuvant Chemotherapy for Breast Cancer Patients with Four or More Positive Axillary Lymph Nodes: A Preliminary Report of a Randomized Trial comparing C.M.F. (Cycophosphamide, Methotrexate and 5- Fluorouracil) versus C.X.F. (Cyclophosphamide, Mitoxantrone and 5-Fluorouracil). American Society of Clinical Oncology, Volume 11, 96, San-Diego, California, May 17-19, 1992.
17. Kaufman, B., Gez,. Feigin, E., Wygoda, M., Uziely, B., Isacson, R., Shnider, B., Catane, R.: Reduction of M-Vac Toxicity by Leucovorin. Proceedings, Eighty-third Annual Meeting of the American Association for Cancer Research, Vol. 33, 1310, San Diego California, May 20-23, 1992.
18. Uziely, B., Dorambus, D., Brufman, G., Lewin, A., Catane, R., Mor -Yosef, S.: The Effect of Tamoxifen on the Endometrium. Proceedings, Eighty-third Annual Meeting of the American Association for Cancer Research, Vol. 33:1678, San Diego, California, May 20-23, 1992.
19. Gabizon, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Barenholz, Y., Huang A.: A Pilot Study of Doxorubicin Encapsulated in Long Circulation (StealthR) Liposomes (S- DOX) in Cancer Patients. Vol. 33:318, San Diego, California, May 20-23, 1992.
20. Uziely, B., Peretz, T., Shiloni, E., Isacson, R., Seror, D., Kaufman, Catane, R.: A Perioperative Chemotherapy (XMF) for Breast Cancer. Adjuvant Therapy of Primary Breast Cancer. 4th International Conference, Abs. #39, 1992.
21. Uziely, B.: Extent of Prior Treatment: Only Predictor for Tazol-Associated Neutropenic Fever (NF)? American Society of Clinical Oncology, Abs. #416, Orlando, Florida, May 16-19, 1993.
22. Baider, L., Uziely, B,. Kaplan De-Nour, A: Long-term Effect of Progressive Muscle Relaxation with Guided Imagery in Highly Distressed Cancer Population. The Seventh European Conference on Clinical Oncology and Cancer Nursing. Abs. #60, Eur. J. Cancer, 29A, Suppl. 6, 1993.
23. Uziely, B., Delaflor-Weiss, E., Russell, C., Leichman, G., Hanisch, R., Spicer, D., Muggia, F., Press, M.: Refractory Breast Cancer Treatment with Taxol: Correlations with MDR. Clinical Oncology and Cancer Nursing. Abs. #423, Eur. J. Cancer, 29A, Suppl. 6, 1993.
24. Mor-Yosef, S., Shushan, A,. Uziely, B. Lewin, A., Peretz, T.: The Effect of Prolonged Tamoxifen Adminstration on the Endometrium and Ovaries of Women with Breast Cancer. International Journal of Gynecological Cancer 5(1) 23(#76), 1995.
25. Gabizon, A., Uziely, B., Isacson, R.,Lotem, M., Yehoshua, Z., Tzemach, D., Gera-Ben Dor, C. Ganclin B, Brufman G.: Dose-Schedule Optimization and Pharmacokinetics of Doxil in Metastatic Breast Cancer, (Abs-512), Breast Cancer Research and Treatment. 19th Annual San Antonio Breast Cancer Symposium, 1997.
26. Lyass, O., Uziely B, Heching, N.I, Libson, E., Brufman, G., Gabizon, A.: Doxil in Metastatic Breast Cancer after Prior Chemotherapy: Therapeutic Results in Two Consecutive Studies. 34th ASCO Meeting, May 1998.
27. Lyass, O., Uziely, B., Heching, N.I., Libson, E., Brufman, G., Gabizon, A.: Therapeutic Efficacy of Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer (MBC) after Prior Chemotherapy: Analysis of the Hadassah Medical Center Experience. 21st Annual, San Antonio Breast Cancer Symposium, December 1998.
28. Miles, D., Uziely, B., Van Bell, S., Squiban P., Ross M., Scholl, S., Rubens R.: A Phase II Study of a Gene-Modified Vaccinia Virus Expressing MUC-1 and Interleukin-2 in Patients with Metastatic Breast Cancer. ASCO, Vol 18: 1684, May 1999.
29. Lyass, O., Uziely B., Peretz, T., Hubert, A., Brufman, G.: Weekly Vinorelbine (VNB) in the Treatment of Metastatic Breast Cancer (MBC): ASCO, Vol 19: 448, May 2000.
Publications
1. Uziely, B., Sulkes, A., Libson, E., Isacson, R., Ben-Baruch, N., Gez, E., Efrat-Warner, E., Niran, S., Fridkin, M., Catane, R.: A Phase III Study of Tuftsin for the Treatment of Non-small Cell Carcinoma of the Lung. Proceedings of 4th Mediterranean Congress of Chemotherapy, 1166-1167, 1984.
2. Catane, R., Sulkes, A., Uziely, B., Gez, E., Isacson, R., Treves, A.J., Fridkin, U.: Initial Clinical Studies with Tuftsin. Int. J. Immunotherapy II. 81-85, 1985 1.889;45/116)
3. Feinmesser, R., Libson, Y., Uziely, B., Gay, I.: Metastatic Carcinoma to the Temporal Bone. American Journal of Otology, 7:119-121, 1986. (0.956; 9/26;4)
4. Gez, E., Warner-Efrati, E., Ben-Yosef R., Ben-Baruch, N., Yitzhaki, N., Uziely, B., Brufman, G., Biran, S.: High-Dose Metoclopramide and Dexamethasone as an Antiemetic in Outpatients Receiving Chemotherapy for Breast Cancer: Second Study. Oncology, 44:237-239, 1987. (2.141; 30/101;3).
5. Michaeli, J., Lugassy, G., Ray, I., Uziely, B., Polliack, A.: Chronic Lymphocytic Leukemia and Malignant Lymphoma Developing in Patients with Autoimmunity or other Ill-defined Immune Stigmata: A Review of the Literature and Report of an Additional Nine Cases: Hematology Reviews, 1: 291-310, 1987. (2)
6. Sulkes, A., Uziely, B,. Isacson, R., Brufman, G., Biran, S: Combination Chemotherapy in Metastatic Tumors of Unknown Origin. 5-Fluorouracil, Adriamycin and Mitomycin C for Adenocarcinomas and Adriamycin, Vinblastine and Mitomycin C for Anaplastic Carcinomas. Israel Journal of Medical Sciences, 24: 604-610, 1988. (0.508; 53/100;3).
7. Polliack, A., Uziely, B., Isacson, R., Lugassy, G., Rochlemer, S., Gez, E., Libson, E., Sulkes, A. and Weshler, Z.: Diffuse Large Cell Non-Hodgkin’s Lymphoma: Results of M-BACOD Combination Chemotherapy. Israel Journal of Medical Sciences 24: 619-622,1988. (0.508; 53/100; 1)
8. Libson, E., Fields, S., Uziely, B., Polliack, D.: Traumatic Closed Iliac Bone Biopsy Defect Simulating Involvement by Hodgkin’s Disease. Computerized Radiol. Medical Imaging and Graphics, 12: 3 187-189, 1988.
9. Uziely B., Peretz, T., Sulkes, A., Feigin, E., Isacson, R., Biran, S.: Cisplatin, Bleomycin and Methotrexate (P.B.M.) Chemotherapy in Locally Advanced and Metastatic Head and Neck Cancer. Journal of Surgical Oncology. 42:234-238, 1989.(0.774;50/114).
10. Israeli, A., Azaria, J.J., Reiss, T., Libson, E., Uziely, B., Michaeli, J.: Right Ventricular Outflow Tract Obstruction due to Extracardiac Tumors. A Report of Three Cases Diagnosed and Followed by Echocardiographic Studies. Arch Intern. Med-Biol 139: 2105-5106, 1989. (4.781; 7/100;4).
11. Uziely, B., Isacson, R., Weshler, Z., Lugassy, G., Libson, E., Polliack, A.: Hodgkin’s Lymphomal Results of ABV Chemotherapy on 40 Patients with Bulky Disease. Leukemia and Lymphoma. 1: 123-127, 1990. (1.046; 34/59).
12. Ilan, Y., Ruchlemer, R., Lugassy, G., Uziely, B., Williams, S.F., Golomb, H.M.,Polliack A.: Report of Five Cases and a Review of the Literature. Leukemia and Lymphoma, 5: 249-254, 1991. (1.046; 34/59;3).
13. Israeli, A., Uziely, B., Biran, S., Penchas, S.: Screening Mammography in Israel. Harefuah, 10; 515-516, 1990 (in Hebrew).
14. Pappo, I., Feigin, E., Uziely, B., Amir, G.: Biliary and Pancreatic Metastases of Breast Carcinoma: Is Surgical Palliation Indicated. Journal of Surgical Oncology 46:211-214, 1991.(0.774; 50/114; 6).
15. Krausz, Y,. Uziely, B ., Ligovetsky, G., Isacson, R., Levinger, E., Catane, R., Karger, H. , Atlan, H. : Scintigraphic Evaluation of Patients with Thyroid Carcinoma -Therapeutic Approaches. Israel Journal of Medical Sciences 28:206-211, 1992. (0.508;53/100).
16. Anteby, I., Pe’er, J., Uziely, B., Krausz, Y.: Thyroid Carcinoma Metastasis to the Choroid Responding to Systemic I131 Therapy. American Journal of Ophthalmology, 113: 461-462, 1992. (1.715; 10139;3).
17. Uziely, B., Lewin, A., Brufman, G., Dorembus, D., Mor-Yosef, S.: The Effect of Tamoxifen on the Endometrium. Breast Cancer Research and Treatment, 26: 101-105, 1993. (2.430; 24/101;27).
18. Krausz, Y., Uziely, B., Darger, H., Isacson, R., Catane, R., Glaser, B.: Recurrence-Associated Mortality in Patients with Differentiated Thyroid Carcinoma. J Surg Oncol ,52:164-168, 1993. (0.774; 05/114;8).
19. Markitsiu, A., Lustman, J., Uziely, B., Krausz, Y., Chisin, R.: Salivary and Lacrimal Gland Involvement in a Patient who had Undergone a Thyoidectomy and was Treated with Radioiodine for Thyroid Cancer. Oral Surg, Oral Med, and Oral Path 75:318-322, 1993. (0.884; 45/14;3).
20. Drakos, P., Uziely, B., Nagler, A., Gillis, S., Eldor, A.: Successful Administration of Low Molecular Weight Heparin in a Patient with Heparin-induced Thrombocytopenia and Coumarin-induced Skin Necrosis.. Haemastasis 23: 259-262,1993. (1.000; 38/59;7).
21. Delaflor-Weiss, E., Uziely, B., Muggia, F. M. : Protracted Drug Infusions in Cancer Treatment: An Appraisal of 5-Fluorouracil, Doxorubicin and Platinums. Annals of Oncology 4:723-733, 1993. (2.548; 22/101;11).
22. Isacson, R., Safra, T., Gera - Ben Dor C., Uziely, B,. Brufman, G.: A Preliminary Report of a Pilot Randomized Trial Comparing Cyclophosphamide, Methotrexate and 5-Fluorouracil with Cyclophosphamide, Mitoxantrone and 5-Fluorouracil in the Adjuvant Therapy of Stage II Breast Cancer with Four or More Positive Axillary Nodes. Anti Cancer Drugs. 4:187-192, 1993. (0.985; 62/101;3).
23. Gabizon, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., Martin, F., Huang, G., Barenholz. Y.: Prolonged Circulation Time and Enhanced Accumulation in Malignant Exudate of Doxorubin Encapsulated in Polyethylene-glycol Coated Liposomes. Cancer Res: 54:987-992, 1994. (8.426; 3/101: 97)
24. Uziely, B., Groshen, S., Jeffers, S., Morris, M., Russell, C., Roman, L., Muderspach, L,. Muggia, F.: Paclitaxel (Taxol) in Heavily Pretreated Ovarian Cancer: Antitumor Activity and Complications. Ann of Oncol, 5:827-833, 1994. (2.548; 22/101;14).
25. Baider, L., Uziely B., Kaplan De-Nour, A.: Progressive Muscle Relaxation and Guided Imagery in Cancer Patients: General Hospital, Psychiatry 16: 340-347, 1994. (1.29; 35/67; 10).
26. Gabizon, A., Isacson, R., Libson, E., Kaufman, B., Uziely, B., Catane, R., Gera - Ben Dor, C. Rabello, E., Cass, Y,. Peretz, T., Sulkes, A., Chisin, R., Barenholz, y.: Clinical Studies of Liposome-encapsulated Doxorubicin, ACTA Oncology, 33:779-796, 1994. (0.776;67/101; 23).
27. Uziely B., Jeffers, S., Isacson, R., Kutsch, K,. Wei-Tsao, D., Yehoshua, A. Libson, E., Muggia, FM,. Gabizon, A.: Liposomal Doxorubicin: Antitumor Activity and Unique Toxicities During Two Complemtary Phase I Studies. Journal of Clinical Oncology 13: 1777-1785, 1995. (7.876; 5/101; 57)
28. Cass, Y., Uziely, B., Heching, N., Ramu, N., Pappo, Y., Peretz, T.: A Multiparous Pregnant Woman Receiving Chemotherapy for Breast Cancer. J. Oncol Pharm Practice 1: 33-39, 1995.
29. Shushan A., Peretz T., Uziely B., Lewin A., and Mor-Yosef , S.: Ovarian Cyst in Premenopausal and Postmenopausol Tamoxifen-treated Women with Breast Cancer. Am J Obstet Gyncol 174:141-144, 1996. (2.556; 3/54;8).
30. Shushan A., Uziely B. and Mor-Yosef S,: Effect of Prolonged Tamoxifen Administration on the Endometrium and Ovaries of Women with Breast Cancer. Journal of Gynecologic Techniques 2:75-80, 1996.
31. Baider L., Perry S., Sison A., Holland, J., Uziely B., Kaplan DeNour A.: The Role of Psychological Variables in a Group of Melonoma Patients: An Israeli Sample. Psychosomatics 38:45-53; 1996. (1.707; 16/42).
32. Formenti S.C., Dunnington G., Uziely B., Lenz H., Keren-Rosenberg , S., Silberman H., Spicer D., Denk M., Leichman G., Groshen S., Watkins K., Muggia F., Florentine B., Press M., Danenberg , K. and Danenberg , P.: Orginial P53 Status Predicts for Pathological Response in Locally Advanced Breast Cancer Patients Treated Preoperatively with Continuous Infusion 5-Fluorouracil and Radiation Therapy. Int. J. Radiation Onc.Biol. Phys. 93:5-1059-1068,1997 . (2.636; 8/75).
33. Muggia, F.M., Hainsworth, S.J., Miller P., Groshen S., Tan M., Roman L., Uziely B., Muderspach L., Garcia A., Burnett A., Greco A.F., Morrow P.C.: Phase II Study of Liposomal Doxorubicin in Refractory Ovarian Cancer: Antitumor Activity and Toxicity Modification by Liposomal Encapsulation, Journal of Clinical Oncolgy 15:3 , 987-993, 1997. (7.878; 5/10; 36).
34. Baider L., Uziely B., Kaplan DeNour A.: The Impact of Perceived Behavior on Patient Physician Satisfaction. Annals of the New York Academy of Science, 809:266-278,1997 (0.903; 17/56)
35. Formenti, S.C., Dunnington, G., Uziely, B., Lenz, H., Keren-Rosenberg, S., Silberman H., Spicer, D., Denk, M., Leichman, G., Groshen, S., Watkins, K., Muggia, F., Florentine, B., Press, M., Danenberg, K., Danenberg, P.: Orginial p53 Status Predicts for Pathological Response in Locally Advanced Breast Cancer Patients Treated Preoperatively with Continuous Infusion 5-Fluorouracil and Radiation Therapy. Int J Radiat Oncol Biol Phys. 1:39(5): 1059-68, 1997.
36. Even-Ram , S., Uziely, B., Cohen, P., Grisaru-Granovsky, S., Maoz, M., Reich, R., Vlodavsky, I., Bar-Shavit, R.: Thrombin Receptor Overexpression in Malignant Physiological Invasion Processes. Nature Medicine, 4: 909-914, 1998. (28.114; 1/61; (3/253).
37. Kadouri, L., Gips, M., Hubert, A., Sagi, M., Heching N., Lerer, I., Uziely, B., Weinberg, N., Abeliovich, D., Peretz T.: Genetic Testing of Breast and Ovarian Cancer Patients: Clinical Characteristics and Hormonal Risk Modifiers; European Journal of Obstetrics & Gynecology and Reproductive Biology 85: 75-80 , 1999. (0.549; 34/54).
38. Yang, X., Uziely, B., Groshen, S., Lukas, J., Israel, V., Russell, C., Dunnington G., Formenti, S., Muggia, F., Press, MF.: MDRI Gene Expression in Primary and Advanced Breast Cancer. Lab. Invest. 79(3):271-80, 1999.
39. Lyass, O., Uziely, B., Ben-Yosef, R., Tzemach, D., Heching, N.I., Lotem, M., Brufman, G., Gabizon, A.: Correlation of Toxicity with Pharmacokinetics of Pegylated Liposomal Doxorubicin (Doxil) in Metastatic Breast Cancer. Cancer 89(5): 1037-47,
40. Krausz, Y., Uziely, B., Nesher, R., Chisin ,R., Glaser, B: Recombinant TSH in Differentiated Thyroid Cancer. The Israel Medical Association Journal; 3;843-849, 2001
41. Pokroy, E., Uziely, B., Cohen Even-Ram S., Maoz, M., Cohen, I., Ochayon, S., Reich R., Pe'er, J., Drize, O., Lotem, M., Bar-Shavit, R.: Protease Activated Receptors (PARs) are Invloved in Cutaneous and Uveal Melanoma Progression. Cancer Research (submitted)
42. Kadouri, L., Hubert, A., Abeliovich, D., Ever-Hadani, P., Gips, M., Sagi, M., Shushan, A., Lerer, I., Uziely, B., Heshing, I., Guatta, Z., Amir, G., Peretz, T.: Clinical Presentation of BRCA1/2 Carriers - The Impact of Hormonal Factors. Clinical Cancer Research (submitted).
More in PubMed